James L Greenwald, MD | |
475 Irving Ave, Ste 200, Syracuse, NY 13210-1756 | |
(315) 464-4686 | |
(315) 464-7106 |
Full Name | James L Greenwald |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 46 Years |
Location | 475 Irving Ave, Syracuse, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093733859 | NPI | - | NPPES |
00630933 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 145822 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Upstate Family And Preventive Medicine Inc | 6800185711 | 22 |
News Archive
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.
The monoclonal antibody secukinumab is approved for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of six years who are candidates for systemic therapy.
Slimmer Silhouette is excited to announce the Perfect 10 Challenge, an engaging health and life-makeover challenge for 2010 that encourages women in leadership positions at charities and non-profit organizations nationwide to champion their cause by taking better care of themselves.
Genaissance Pharmaceuticals received a Notice of Allowance from the United States Patent and Trademark Office for a patent claiming methods for identifying correlations between the safety and efficacy of drugs and patients' unique genetic signatures.
› Verified 5 days ago
Entity Name | Upstate Family And Preventive Medicine Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073988911 PECOS PAC ID: 6800185711 Enrollment ID: O20160517000789 |
News Archive
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.
The monoclonal antibody secukinumab is approved for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of six years who are candidates for systemic therapy.
Slimmer Silhouette is excited to announce the Perfect 10 Challenge, an engaging health and life-makeover challenge for 2010 that encourages women in leadership positions at charities and non-profit organizations nationwide to champion their cause by taking better care of themselves.
Genaissance Pharmaceuticals received a Notice of Allowance from the United States Patent and Trademark Office for a patent claiming methods for identifying correlations between the safety and efficacy of drugs and patients' unique genetic signatures.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
James L Greenwald, MD 475 Irving Ave, Ste 200, Syracuse, NY 13210-1756 Ph: (315) 464-4686 | James L Greenwald, MD 475 Irving Ave, Ste 200, Syracuse, NY 13210-1756 Ph: (315) 464-4686 |
News Archive
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.
The monoclonal antibody secukinumab is approved for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of six years who are candidates for systemic therapy.
Slimmer Silhouette is excited to announce the Perfect 10 Challenge, an engaging health and life-makeover challenge for 2010 that encourages women in leadership positions at charities and non-profit organizations nationwide to champion their cause by taking better care of themselves.
Genaissance Pharmaceuticals received a Notice of Allowance from the United States Patent and Trademark Office for a patent claiming methods for identifying correlations between the safety and efficacy of drugs and patients' unique genetic signatures.
› Verified 5 days ago
Amy Elizabeth Roy, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 E Genesee St, Suite 300, Syracuse, NY 13210 Phone: 315-471-1044 Fax: 315-474-4312 | |
Andrew Paul Aiken, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Va Medical Center Outpatient Cardiology, Syracuse, NY 13210 Phone: 315-425-4400 | |
Pamela Sue Horst, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 301 Prospect Ave, Palliative Care, Syracuse, NY 13203 Phone: 315-448-5175 Fax: 315-448-3557 | |
Amogechukwu N Okonkwo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 819 S Salina St, Syracuse, NY 13202 Phone: 315-476-7921 Fax: 315-475-1448 | |
Kevin E Gaskin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4363 Fax: 315-464-8690 | |
Brigitte Mcgrath, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 847 James St, Syracuse, NY 13203 Phone: 315-471-1184 | |
Matthew Micco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Prospect Ave, Syracuse, NY 13203 Phone: 315-448-5536 |